Yes, Gerry needs to prove himself first and any acquisition will further demonstrate to the market and analysts that they are the B Suite of leadership and management. At this point of time, my concern is that they might not be locking in prices later 2022 and 23. Very little information about their practices on forward orders is available. Looking forward to the April update and report. King Julian
- Forums
- ASX - By Stock
- CRN
- W-8BEN form
W-8BEN form, page-5
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.15 |
Change
0.005(0.44%) |
Mkt cap ! $1.919B |
Open | High | Low | Value | Volume |
$1.16 | $1.16 | $1.14 | $153.8K | 134.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4698 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 23586 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 48482 | 1.145 |
11 | 19626 | 1.140 |
10 | 37386 | 1.135 |
10 | 101340 | 1.130 |
5 | 287570 | 1.125 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 25082 | 19 |
1.155 | 25885 | 13 |
1.160 | 39104 | 12 |
1.165 | 114877 | 12 |
1.170 | 33962 | 9 |
Last trade - 11.21am 11/10/2024 (20 minute delay) ? |
Featured News
CRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online